August 13, 2018
Article
In addition to other updates, new breakpoints have been added for cefiderocol and meropenem-vaborbactam.
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot
Estrogen Treatment Reduces Risk of COVID-19 Mortality
FDA Approves Pfizer-BioNTech Booster Shot for Children 5 and Older
An Issue About COVID-19